Empliciti (elotuzumab) / AbbVie, BMS  >>  Phase 1
Welcome,         Profile    Billing    Logout  

9 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Empliciti (elotuzumab) / AbbVie, BMS
NCT00425347: Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma

Completed
1
35
US
HuLuc63
Facet Biotech
Multiple Myeloma
08/08
07/09
NCT01241292: Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone

Checkmark P1 data-ASCO
Jun 2012 - Jun 2012: P1 data-ASCO
Completed
1
7
Japan
BMS-901608 (Elotuzumab) 10 mg, BMS-901608 (Elotuzumab) 20 mg
Bristol-Myers Squibb
Multiple Myeloma
02/14
01/17
NCT01393964: Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

Completed
1
35
US
Lenalidomide, Revlimid®, Dexamethasone, Decadron®, Dexamethasone Intensol®, Dexpak® Taperpak®, Elotuzumab (BMS-901608; HuLuc63)
Bristol-Myers Squibb, AbbVie
Multiple Myeloma
03/14
07/16
NCT02655458: Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma

Completed
1
15
US
Elotuzumab, Empliciti, Lenalidomide, Revlimid, autologous PBMC reconstitution, ASCT, auto-SCT consolidation therapy
Hearn Jay Cho, Bristol-Myers Squibb
Multiple Myeloma
07/17
07/17
NCT02252263: A Phase I Open Label Study of the Safety and Tolerability of Elotuzumab (BMS-901608) Administered in Combination With Either Lirilumab (BMS-986015) or Urelumab (BMS-663513) in Subjects With Multiple Myeloma

Completed
1
44
US, Europe
Elotuzumab, BMS-901608, Lirilumab, BMS-986015, Urelumab, BMS-663513
Bristol-Myers Squibb
Multiple Myeloma
10/17
10/17
NCT03023527: Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma

Terminated
1
6
Europe
Nivolumab, Pomalidomide, Dexamethasone, Elotuzumab
PETHEMA Foundation, Celgene, Bristol-Myers Squibb, Adknoma Health Research, S.L.
Multiple Myeloma
01/18
01/18
NCT04614636: FT538 in Subjects With Advanced Hematologic Malignancies

Terminated
1
42
US
FT538, Cyclophosphamide, Fludarabine, Daratumumab, Darzalex, Elotuzumab, Empliciti
Fate Therapeutics
Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma, Myeloma
07/23
08/23
CC-220, NCT05560399: A Study of Iberdomide () in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma

Active, not recruiting
1
7
US
Iberdomide, CC-220, Elotuzumab, Dexamethasone
Icahn School of Medicine at Mount Sinai, Multiple Myeloma Research Consortium, Bristol-Myers Squibb
Multiple Myeloma
11/26
12/26
NCT05981209: Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies

Recruiting
1
27
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, CT, CT Scan, tomography, Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycadron, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decadron DP, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasone Intensol, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Dxevo, Fluorodelta, Fortecortin, Gammacorten, Hemady, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, TaperDex, Visumetazone, ZoDex, Echocardiography, EC, Elotuzumab, BMS-901608, Empliciti, HuLuc-63, HuLuc63, PDL-063, PDL063, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, Mezigdomide, BMS 986348, BMS-986348, BMS986348, CC 92480, CC-92480, CELMoD CC-92480, Cereblon E3 Ligase Modulation Drug CC-92480, Cereblon E3 Ubiquitin Ligase Modulating Agent CC-92480, Cereblon Modulator CC-92480, X-Ray Imaging, Conventional X-Ray, Diagnostic Radiology, Medical Imaging, X-Ray, Plain film radiographs, Radiographic Imaging, Radiographic imaging procedure (procedure), Radiography, RG, Static X-Ray, X-Ray
Abdullah Khan
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
12/25
12/25

Download Options